PACIRA PHARMACEUTICALS
Pacira Pharmaceuticals provides medical and product information services. Pacira Pharmaceuticals provides gynecologic surgery, maxillofacial surgery, orthopedic surgery, bariatric surgery, pediatric surgery, breast surgery, shoulder surgery, colorectal, general surgery, and spine surgery.
PACIRA PHARMACEUTICALS
Industry:
Cosmetic Surgery Health Care Medical Personal Health
Founded:
2012-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.exparel.com
Status:
Active
Contact:
+1 855 793 9727
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Apache
Official Site Inspections
http://www.exparel.com Semrush global rank: 1.4 M Semrush visits lastest month: 20.29 K
- Host name: server-3-171-76-16.iad89.r.cloudfront.net
- IP address: 3.171.76.16
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Pacira Pharmaceuticals"
Patient and practice resources - EXPAREL pro
Jan 1, 2025 Important Safety Information. EXPAREL is contraindicated in obstetrical paracervical block anesthesia. Adverse reactions reported in adults with an incidence greater than or equal to 10% following EXPAREL …See details»
EXPAREL – Pacira
EXPAREL is the only non-opioid option approved to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an …See details»
EXPAREL | Non-opioid Analgesic Pain Management
Jan 1, 2025 EXPAREL is not recommended to be used in the following patient populations: patients <6 years old for infiltration, patients younger than 18 years old for nerve blocks, and/or pregnant patients. Because amide-type local …See details»
Regulatory Decision Summary for Exparel - Drug and Health …
Exparel . Date of decision: 2021-08-05. Manufacturer: Pacira Ltd. Drug Identification Numbers issued: N/A; Prescription status: Date filed: 2019-08-03. Contact: Bureau of Cardiology, …See details»
EXPAREL | Patient-Coverage
EXPRESS YOUR RECOVERY WITH EXPAREL ®. Patients and doctors often don’t fully discuss pain management options before surgery. Administered during surgery, EXPAREL ® is a non …See details»
OPIOID-MINIMIZING POSTSURGICAL PAIN MANAGEMENT WITH
EXPAREL is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional analgesia in adults via an interscalene brachial plexus nerve …See details»
022496Orig1s000 - Food and Drug Administration
EXPAREL has not been studied for use in patients younger than 18 years of age. 2. DOSAGE AND ADMINISTRATION EXPAREL is intended for single-dose administration only. The …See details»
Characterization of Exparel Bupivacaine Multivesicular …
Exparel is a liposomal bupivacaine formulation, which can locally release bupivacaine over an extended period of 48-72 h [1-3]. Exparel was first approved by FDA in 2011 for single infiltration to provide postsurgical local analgesia.See details»
Exparel Market Size, Share, Trends | Growth Report, 2033
Mar 24, 2025 EXPAREL MARKET REPORT OVERVIEW. The global exparel market, valued at USD 0.69 billion in 2024, is forecasted to grow consistently, reaching USD 0.73 billion in 2025 …See details»
Exparel - Overview, News & Similar companies | ZoomInfo.com
Who is Exparel. EXPAREL (bupivacaine liposome injectable suspension) is indicated in patients 6 years of age and older for single-dose infiltration to produce post surgical local analgesia, and …See details»
HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE FORMS …
%PDF-1.7 %µµµµ 1 0 obj >/Metadata 3666 0 R/ViewerPreferences 3667 0 R>> endobj 2 0 obj > endobj 3 0 obj >/ExtGState >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI ...See details»
EXPAREL | Non-opioid Analgesic Pain Management
Jan 1, 2025 EXPAREL ® (bupivacaine liposome injectable suspension) is indicated to produce postsurgical local analgesia via infiltration in patients aged 6 years and older and regional …See details»
Exparel (bupivacaine) - Uses, Side Effects, and More - WebMD
For more information about Exparel, you can visit the manufacturer’s website at www.exparel.com or call them at 855-RX-EXPAREL (855-793-9727). Interactions Does Exparel interact with …See details»
OMFS FAQ - EXPAREL pro
Refer to Important Safety Information on page 8. 2 For more information, please visit www.EXPAREL.com or call 1-855-793-9727. OMFS FAQ EXPAREL is a long-lasting, non …See details»
Pacira BioSciences Announces Settlement of U.S. Patent
Apr 7, 2025 Pacira has three commercial-stage non-opioid treatments: EXPAREL ® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved …See details»
Non-Opioid Pain Medication - EXPAREL
EXPRESS YOUR RECOVERY WITH EXPAREL ®. Patients and doctors often don’t fully discuss pain management options before surgery. Administered during surgery, EXPAREL ® is a non …See details»
Exparel: Side effects, dosage, how long it lasts, uses, and more
Dec 12, 2021 Exparel (bupivacaine) is a brand-name injection used for pain relief as a nerve block or local analgesic. Learn about its side effects, dosage, and more.See details»
Pacira BioSciences, Inc. Authorizes $300 Million Share ... - Nasdaq
1 day ago Pacira's main products include EXPAREL, ZILRETTA, and iovera°, offering innovative alternatives to opioid pain management. Disclaimer: This is an AI-generated summary of a …See details»
Unlocking Pain Relief: A Comprehensive Guide to Exparel Dosage, …
Dec 19, 2024 Exparel is a liposomal formulation of bupivacaine used for managing postoperative pain, offering prolonged analgesic effects through local infiltration at the surgical site. This …See details»
Oral Surgery Pain Management: The Opioid Free Option - EXPAREL
EXPRESS YOUR RECOVERY WITH EXPAREL ®. Patients and doctors often don’t fully discuss pain management options before surgery. Administered during surgery, EXPAREL ® is a non …See details»